Pancreatic cancer is a deadly type of cancer that is difficult to diagnose early and hard to treat. Chemotherapy can have severe side effects, but a new treatment using nanoparticles could be more precise and cause fewer side effects. The nanoparticles deliver the drug directly to the tumor, sparing healthy cells and reducing toxic effects. They also bypass the resistance mechanisms in the tumor that make regular chemotherapy less effective. The research team from the Max Planck Institute, University Medical Center Göttingen, and the Karlsruhe Institute of Technology has worked together to develop this new treatment. The next step is to optimize the treatment for clinical use. This successful interdisciplinary collaboration has led to the development of a new therapeutic approach for pancreatic cancer. The scientists are now working to bring this new treatment out of the test phase and into clinical use as quickly as possible.
>>Join our Facebook Group be part of community. <<